whatshot

SER   $1.28  -4.48% Market Closed After Close 1.56 21.88%

Serina Therapeutics, Inc.
show_chart Advanced Chart of SER

Current temperature: 24.52
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 2
Target Price Mean 13.00
Mean unverified/preliminary 13.00 / 13.00
Target Price Low / High 11.00 / 15.00
Median / STD DEV 13.00 / 2.83
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy ActivelyBuy ActivelyBuy
rsi Sell ActivelyBuy ActivelyBuy
macd None None None
stoch None None None
ma20 None Buy None
ma50 None None None
ma100 Buy ActivelyBuy ActivelyBuy
Candlestick PatternMarch 18, 2026 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US81751A1088
ceo Mr. Steven A. Ledger
Website https://serinatherapeutics.com
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252, a POZ conjugate for the treatment of Parkinson's disease. The company also develops SER 227 for long-acting pain relief; SER 214 to treat Parkinson's disease; and SER 228 for the treatment of epilepsy. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.